Treatment with cystamine reduces apoptosis in liver from NZB/W F1 mice

International Immunopharmacology

Volumn 8, Issue 4, 2008, Pages 589-596

  Tzang, Bor Show ^a   Chiang, Szu Yi ^b   Lai, Wen Xian ^a   Tsai, Chun Chou ^a   Wu, Jen Huang ^a   Hsu, Tsai Ching ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b Hualien Hospital   (Taiwan)

Author keywords

Apoptosis; Cystamine; Liver; NF B; Systemic lupus erythematosus (SLE)

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 8; CYSTAMINE; CYTOCHROME C; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; PROTEIN DERIVATIVE; TBID PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ASSAY; EXPERIMENTAL STUDY; FEMALE; LIVER; MITOCHONDRION; MOUSE; NEW ZEALAND BLACK MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION;

EID: 39949083753     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.01.010     Document Type: Article

References (46)

1. B.H. Hahn An overview of the pathogenesis of systemic lupus erythematosus D.J. Wallace B.H. Hahn Dubois' lupus erythematosus 1993 Williams and Wilkins Philadelphia 69 76
2. J. Guarize S. Appenzeller L.T. Costallat Skin damage occurs early in systemic lupus erythematosus and independently of disease duration in Brazilian patients Rheumatol Int 27 5 2007 483 487
3. C.P. Chung I. Avalos A. Oeser T. Gebretsadik A. Shintani P. Raggi High frequency of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors Ann Rheum Dis 66 2007 208 214
4. K. Baraczka K. Nekam T. Pozsonyi L. Jakab M. Szongoth M. Sesztak Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement Neuroimmunomodulation 9 2001 49 54
5. H. Bagavant U.S. Deshmukh F. Gaskin S.M. Fu Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage Scand J Immunol 60 2004 52 63
6. M.H. Al-Maini J.D. Mountz H.A. Al-Mohri E.M. El-Ageb B.M. Al-Riyami K.L. Svenson Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus Lupus 9 2000 132 139
7. M. Mukai T. Bohgaki A. Notoya M. Kohno M. Tateno S. Kobayashi Liver dysfunction due to apoptosis in a patient with systemic lupus erythematosus Lupus 9 2000 74 77
8. I.K. Mackay L.I. Taft D.C. Cowling Lupoid hepatitis and the hepatic lesions of SLE Lancet 5 1959 65 69
9. Runyon D.R. LaBrecque S. Anuras The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature Am J Med 69 1980 187 194
10. S. Abraham S. Begum D. Isenberg Hepatic manifestations of autoimmune rheumatic diseases Ann Rheum Dis 63 2004 123 129
11. B. Kovacs S.N. Liossis G.J. Dennis G.C. Tsokos Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus Autoimmunity 25 1997 213 221
12. J. McNally D.H. Yoo J. Drappa J.L. Chu H. Yagita S.M. Friedman Fas ligand expression and function in systemic lupus erythematosus J Immunol 159 1997 4628 4636
13. B.C. Trauth C. Klas A.M. Peters S. Matzku P. Moller W. Falk Monoclonal antibody-mediated tumor regression by induction of apoptosis Science 245 1989 301 305
14. R. Watanabe-Fukunaga C.I. Brannan N. Itoh S. Yonehara N.G. Copeland N.G. Copeland N.A. Jenkins The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen, J Immunol. 148 1992 1274 1279
15. Z. Szondy Z. Sarang P. Molnar T. Nemeth M. Piacentini P.G. Mastroberardino Transglutaminase 2−/− mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells Proc Natl Acad Sci USA 100 2003 7812 7817
16. G.E. Grossmayer L.E. Munoz U.S. Gaipl S. Franz A. Sheriff R.E. Voll Removal of dying cells and systemic lupus erythematosus Mod Rheumatol 15 2005 383 390
17. U.S. Gaipl A. Kuhn A. Sheriff L.E. Munoz S. Franz R.E. Voll Clearance of apoptotic cells in human SLE Curr Dir Autoimmun 9 2006 173 187
18. J.E. Folk Transglutaminases Annu Rev Biochem 49 1980 517 531
19. L. Lorand S.M. Conrad Transglutaminases Mol Cell Biochem 58 1984 9 35
20. M. Lesort M. Lee J. Tucholski G.V. Johnson Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders J Biol Chem 278 2003 3825 3830
21. R. Ientile A. Campisi G. Raciti D. Caccamo M. Curro G. Cannavo Cystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells J Neurosci Res 74 2003 52 59
22. T.M. Jeitner E.J. Delikatny J. Ahlqvist H. Capper A.J. Cooper Mechanism for the inhibition of transglutaminase 2 by cystamine Biochem Pharmacol 69 2005 961 970
23. M.V. Karpuj M.W. Becher J.E. Springer D. Chabas S. Youssef R. Pedotti Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine Nat Med 8 2002 143 149
24. T.C. Hsu S.Y. Chiang C.Y. Huang G.J. Tsay C.W. Yang C.N. Huang Beneficial effects of treatment with transglutaminases inhibitor cystamine on macrophage response in NZB/W F1 mice Exp Biol Med (Maywood) 232 2007 195 203
25. A.M. Denman E.J. Denman E.J. Holborow Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin Lancet. 1 1967 1084 1086
26. E.J. Holborow A.M. Denman Autoimmune disease in inbred mice Clin Exp Immunol. 2 1967 761 767
27. A.S. Russell A.M. Denman Normal induction and maintenance of tolerance in (NZBxNZW) F1 mice Clin Exp Immunol. 5 1969 265 272
28. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 684
29. L. Zhang X. Wang W. Zheng M. Shi The effects of interleukin-10 on the expression of Fas and FasL in rat hepatic stellate cells Med Chem 2 2006 611 616
30. B. Mignotte J.L. Vayssiere Mitochondria and apoptosis Eur J Biochem 252 1998 1 15
31. D.R. Green J.C. Reed Mitochondria and apoptosis Science 281 1998 1309 1312
32. C. Rust G.J. Gores Apoptosis and liver disease Am J Med 108 2000 567 574
33. G. Feldmann C. Lamboley A. Moreau A. Bringuier Fas-mediated apoptosis of hepatic cells Biomed Pharmacother 52 1998 378 385
34. K. Seino N. Kayagaki K. Takeda K. Fukao K. Okumura H. Yagita Contribution of Fas ligand to T cell-mediated hepatic injury in mice Gastroenterology 113 1997 1315 1322
35. Y. Amasaki S. Kobayashi T. Takeda N. Ogura S. Jodo T. Nakabayashi Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia Clin Exp Immuno l 99 1995 245 250
36. R. Ksontini D.B. Colagiovanni M.D. Josephs C.K. Edwards 3rd C.L. Tannahill C.C. Solorzano Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis J Immunol 160 1998 4082 4089
37. A. Canbay S. Friedman G.J. Gores Apoptosis: the nexus of liver injury and fibrosis Hepatology 39 2004 273 278
38. D.E. Wesche-Soldato C.S. Chung J. Lomas-Neira L.A. Doughty S.H. Gregory A. Ayala In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice Blood 106 2005 2295 2301
39. C.Y. Wang M.W. Mayo R.G. Korneluk D.V. Goeddel A.S. Baldwin NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation Science 281 1998 1680 1683
40. H.G. Zhang N. Huang D. Liu L. Bilbao X. Zhang P. Yang Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts Arthritis Rheum 43 2000 1094 1105
41. H. Nakayama T. Ikebe M. Beppu K. Shirasuna High expression levels of nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity Cancer 92 2001 3037 3044
42. S. Maeda H. Yoshida Y. Mitsuno Y. Hirata K. Ogura Y. Shiratori Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori Mol Pathol 55 2002 286 293
43. B.R. Schram T.L. Rothstein NF-kappa B is required for surface Ig-induced Fas resistance in B cells J Immunol 170 2003 3118 3124
44. S. Shishodia G. Sethi M. Konopleva M. Andreeff B.B. Aggarwal A synthetic triterpenoid, CDDO-Me, inhibits IkappaB alpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappa B-regulated gene products in human leukemic cells Clin Cancer Res 12 2006 1828 1838
45. S. Kim I. Millet H.S. Kim J.Y. Kim M.S. Han M.K. Lee NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice Proc Natl Acad Sci USA 104 2007 1913 1918
46. R. Dubinsky C. Gray CYTE-I-HD: phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's disease Mov Disord 21 2006 530 533